MISSION
GXP BioTechnology, LLC is committed to developing small molecule drugs For Good Health that regulate SREBP transcription factors and related pathways for the prevention and treatment of metabolic diseases and cancer.
Our mission is driven by over 60 years of groundbreaking discoveries in fat and energy metabolism by our company’s founders. GXP BioTechnology operates in a competitive industry with established companies like Bio-Rad Laboratories, Danaher Corporation, and Thermo Fisher Scientific Inc. Understanding the strategies and offerings of these competitors can provide insights into market positioning and differentiation opportunities.
Learn more about Our Technology